Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. inflammatory reflex
Show results for
Products
Applications

Companies

News
Articles

Refine by
Date

  • Older

Inflammatory Reflex Articles & Analysis

10 news found

SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs

SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs

SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform designed to stimulate the vagus nerve to ...

BySetpoint Medical Corporation


Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical

Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical

The company is pioneering a new treatment paradigm, using electrical pulses that activate the body’s innate “inflammatory reflex,” for rheumatoid arthritis (RA), Crohn’s disease and other chronic autoimmune diseases as a safe, cost-effective alternative to drugs and biologics. “SetPoint is reshaping the treatment paradigm of chronic ...

BySetpoint Medical Corporation


SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows

SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows

SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate ...

BySetpoint Medical Corporation


SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform

SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform

SetPoint’s investigational bioelectronic medicine platform stimulates the vagus nerve to activate the endogenous inflammatory reflex and thereby reduce inflammation. The Company has received FDA Investigational Device Exemption (IDE) approval for a multicenter, double-blind, randomized, sham controlled pivotal trial that will enroll up to 250 patients at ...

BySetpoint Medical Corporation


The Lancet Rheumatology publishes clinical trial data demonstrating promising safety and efficacy profile for a Novel Bioelectronic Device in patients with drug refractory rheumatoid arthritis

The Lancet Rheumatology publishes clinical trial data demonstrating promising safety and efficacy profile for a Novel Bioelectronic Device in patients with drug refractory rheumatoid arthritis

” “These new data confirm that activation of the cholinergic anti-inflammatory pathway by vagus nerve stimulation can reduce disease activity even in patients who have failed to respond to multiple classes of biological drugs and JAK inhibitors,” said Dr. ...

BySetpoint Medical Corporation


The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in patients with Drug Refractory Rheumatoid Arthritis

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in patients with Drug Refractory Rheumatoid Arthritis

” “These new data confirm that activation of the cholinergic anti-inflammatory pathway by vagus nerve stimulation can reduce disease activity even in patients who have failed to respond to multiple classes of biological drugs and JAK inhibitors,” said Dr. ...

BySetpoint Medical Corporation


SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients

SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients

SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate ...

BySetpoint Medical Corporation


SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate ...

BySetpoint Medical Corporation


SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate ...

BySetpoint Medical Corporation


Setpoint Medical announces oral presentation of results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019

Setpoint Medical announces oral presentation of results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019

SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate ...

BySetpoint Medical Corporation

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT